749 related articles for article (PubMed ID: 15372465)
21. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
Heegaard AM; Xie Z; Young MF; Nielsen KL
J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
[TBL] [Abstract][Full Text] [Related]
22. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
[TBL] [Abstract][Full Text] [Related]
23. Attenuation of plasminogen activator inhibitor type-1 promoter activity in serum-stimulated renal epithelial cells by a distal 5' flanking region.
Slack JK; Higgins PJ
Cell Motil Cytoskeleton; 1999 Nov; 44(3):168-76. PubMed ID: 10542365
[TBL] [Abstract][Full Text] [Related]
24. DNA binding of USF is required for specific E-box dependent gene activation in vivo.
Kiermaier A; Gawn JM; Desbarats L; Saffrich R; Ansorge W; Farrell PJ; Eilers M; Packham G
Oncogene; 1999 Dec; 18(51):7200-11. PubMed ID: 10602473
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia.
Weigert C; Brodbeck K; Klopfer K; Häring HU; Schleicher ED
Diabetologia; 2002 Jun; 45(6):890-8. PubMed ID: 12107734
[TBL] [Abstract][Full Text] [Related]
26. Role of CAGA boxes in the plasminogen activator inhibitor-1 promoter in mediating oxidized low-density lipoprotein-induced transcriptional activation in mesangial cells.
Kim BC; Song CY; Hong HK; Lee HS
Transl Res; 2007 Sep; 150(3):180-8. PubMed ID: 17761371
[TBL] [Abstract][Full Text] [Related]
27. Identification of the promoter region of the human betaIGH3 gene.
Yuan C; Yang MC; Zins EJ; Boehlke CS; Huang AJ
Mol Vis; 2004 May; 10():351-60. PubMed ID: 15162097
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
30. Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β.
Nakayama N; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2011 Nov; 22(7):468-78. PubMed ID: 21968503
[TBL] [Abstract][Full Text] [Related]
31. Regulation of transcription of the germ-line Ig alpha constant region gene by an ATF element and by novel transforming growth factor-beta 1-responsive elements.
Lin YC; Stavnezer J
J Immunol; 1992 Nov; 149(9):2914-25. PubMed ID: 1401921
[TBL] [Abstract][Full Text] [Related]
32. Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: minimal role of the proximal E-box cis-acting promoter elements.
Quarles LD; Siddhanti SR; Medda S
J Cell Biochem; 1997 Apr; 65(1):11-24. PubMed ID: 9138076
[TBL] [Abstract][Full Text] [Related]
33. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
Iglesias M; Frontelo P; Gamallo C; Quintanilla M
Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
[TBL] [Abstract][Full Text] [Related]
34. Hunchback sequence binding protein suppresses mouse TGF-beta3 promoter in vitro.
Yamazaki K; Crowe DL; Shuler CF
Biochem Biophys Res Commun; 2006 Aug; 346(3):802-9. PubMed ID: 16781676
[TBL] [Abstract][Full Text] [Related]
35. Identification of a non-canonical E-box motif as a regulatory element in the proximal promoter region of the apolipoprotein E gene.
Salero E; Giménez C; Zafra F
Biochem J; 2003 Mar; 370(Pt 3):979-86. PubMed ID: 12444925
[TBL] [Abstract][Full Text] [Related]
36. Upstream stimulating factor-1 mediates the E-box-dependent transcriptional repression of the plasminogen activator inhibitor-1 gene in human mast cells.
Ma Z; Jhun B; Oh CK
FEBS Lett; 2007 Sep; 581(23):4485-90. PubMed ID: 17765897
[TBL] [Abstract][Full Text] [Related]
37. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
38. Excitotoxic brain lesion modifies binding to a USF binding site acting as a negative regulatory element in the Protease nexin-1 promoter.
Ernø H; Küry P; Nitsch C; Jost JP; Monard D
Mol Cell Neurosci; 1996; 8(1):28-37. PubMed ID: 8923453
[TBL] [Abstract][Full Text] [Related]
39. Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.
Samarakoon R; Higgins PJ
Thromb Haemost; 2008 Dec; 100(6):976-83. PubMed ID: 19132220
[TBL] [Abstract][Full Text] [Related]
40. Targeted inhibition of wound-induced PAI-1 expression alters migration and differentiation in human epidermal keratinocytes.
Li F; Goncalves J; Faughnan K; Steiner MG; Pagan-Charry I; Esposito D; Chin B; Providence KM; Higgins PJ; Staiano-Coico L
Exp Cell Res; 2000 Aug; 258(2):245-53. PubMed ID: 10896775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
